CrystalGenomics, Inc. (083790.KQ)

KRW 2545.0

(0.99%)

Total Debt Summary of CrystalGenomics, Inc.

CrystalGenomics, Inc.'s latest annual total debt in 2023 was 32 Billion USD , down -54.41% from previous year.
CrystalGenomics, Inc.'s latest quarterly total debt in 2024 Q1 was 31.98 Billion KRW , down -0.04% from previous quarter.
CrystalGenomics, Inc. reported annual total debt of 70.19 Billion USD in 2022, down -6.06% from previous year.
CrystalGenomics, Inc. reported annual total debt of 74.72 Billion USD in 2021, up 20.68% from previous year.
CrystalGenomics, Inc. reported quarterly total debt of 33.53 Billion KRW for 2024 Q2, up 20.81% from previous quarter.
CrystalGenomics, Inc. reported quarterly total debt of 32 Billion USD for 2023 FY, down -54.41% from previous quarter.

Annual Total Debt Chart of CrystalGenomics, Inc. (2023 - 2013)

Historical Annual Total Debt of CrystalGenomics, Inc. (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	32 Billion USD	-54.41%
2022	70.19 Billion USD	-6.06%
2021	74.72 Billion USD	20.68%
2020	61.91 Billion USD	1061.68%
2019	5.33 Billion USD	0.0%
2018	- USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%
2015	- USD	0.0%
2014	- USD	0.0%
2013	- USD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	31.98 Billion KRW	-0.04%
2024 Q2	33.53 Billion KRW	20.81%
2023 FY	32 Billion USD	-54.41%
2023 Q1	89.38 Billion USD	27.34%
2023 Q3	75.22 Billion USD	-1.64%
2023 Q2	76.47 Billion KRW	-14.45%
2023 Q4	32 Billion USD	-57.45%
2022 FY	70.19 Billion USD	-6.06%
2022 Q3	9.17 Billion USD	0.0%
2022 Q1	8.71 Billion USD	0.0%
2022 Q4	70.19 Billion USD	664.9%
2021 Q4	- USD	0.0%
2021 FY	74.72 Billion USD	20.68%
2021 Q1	- USD	0.0%
2021 Q3	- USD	0.0%
2020 Q1	- USD	0.0%
2020 Q4	- USD	0.0%
2020 FY	61.91 Billion USD	1061.68%
2020 Q3	- USD	0.0%
2019 FY	5.33 Billion USD	0.0%
2019 Q4	- USD	0.0%
2019 Q1	- USD	0.0%
2019 Q3	- USD	0.0%
2018 Q1	- USD	0.0%
2018 FY	- USD	0.0%
2018 Q4	- USD	0.0%
2018 Q3	- USD	0.0%
2017 Q1	- USD	0.0%
2017 Q4	- USD	0.0%
2017 Q3	- USD	0.0%
2017 FY	- USD	0.0%
2016 Q1	- USD	0.0%
2016 Q3	- USD	0.0%
2016 Q4	- USD	0.0%
2016 FY	- USD	0.0%
2015 Q1	- USD	0.0%
2015 FY	- USD	0.0%
2015 Q4	- USD	0.0%
2015 Q3	- USD	0.0%
2014 Q1	- USD	0.0%
2014 FY	- USD	0.0%
2014 Q4	- USD	0.0%
2014 Q3	- USD	0.0%
2013 Q4	- USD	0.0%
2013 Q3	- USD	0.0%
2013 FY	- USD	0.0%
2013 Q1	- USD	0.0%
2012 Q4	- USD	0.0%

Peer Total Debt Comparison of CrystalGenomics, Inc.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	48.963%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-7843.013%
BINEX Co., Ltd.	53.5 Billion KRW	40.189%
Bioneer Corporation	44.63 Billion KRW	28.308%
Anterogen.Co.,Ltd.	9.74 Billion KRW	-228.561%
MEDIPOST Co., Ltd.	52.33 Billion KRW	38.853%
Helixmith Co., Ltd	20.22 Billion KRW	-58.214%
Chabiotech Co.,Ltd.	449.63 Billion KRW	92.882%
Medy-Tox Inc.	82.83 Billion KRW	61.363%
Peptron, Inc.	9.13 Billion KRW	-250.413%
Amicogen, Inc.	149.59 Billion KRW	78.607%
Genexine, Inc.	67.42 Billion KRW	52.537%
HLB Therapeutics Co.,Ltd.	10.02 Billion KRW	-219.318%
LegoChem Biosciences, Inc.	12.64 Billion KRW	-153.111%
ALTEOGEN Inc.	83.76 Billion KRW	61.796%
PharmaResearch Co., Ltd.	34.3 Billion KRW	6.715%
SillaJen, Inc.	9.69 Billion KRW	-230.045%
JETEMA, Co., Ltd.	130.49 Billion KRW	75.476%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	18.686%
Genomictree Inc.	1.83 Billion KRW	-1644.367%
MedPacto, Inc.	8.6 Billion KRW	-271.952%
D&D Pharmatech	8.13 Billion KRW	-293.435%
EASY BIO,Inc.	82.27 Billion KRW	61.104%
GI Innovation, Inc.	3.72 Billion KRW	-760.107%